Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
N Engl J Med ; 372(1): 40-7, 2015 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-25372658

RESUMO

BACKGROUND: In March 2014, the World Health Organization was notified of an outbreak of Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, and to neighboring countries and has subsequently become the largest epidemic of Ebola virus disease (EVD) to date. METHODS: From March 25 to April 26, 2014, we performed a study of all patients with laboratory-confirmed EVD in Conakry. Mortality was the primary outcome. Secondary outcomes included patient characteristics, complications, treatments, and comparisons between survivors and nonsurvivors. RESULTS: Of 80 patients who presented with symptoms, 37 had laboratory-confirmed EVD. Among confirmed cases, the median age was 38 years (interquartile range, 28 to 46), 24 patients (65%) were men, and 14 (38%) were health care workers; among the health care workers, nosocomial transmission was implicated in 12 patients (32%). Patients with confirmed EVD presented to the hospital a median of 5 days (interquartile range, 3 to 7) after the onset of symptoms, most commonly with fever (in 84% of the patients; mean temperature, 38.6°C), fatigue (in 65%), diarrhea (in 62%), and tachycardia (mean heart rate, >93 beats per minute). Of these patients, 28 (76%) were treated with intravenous fluids and 37 (100%) with antibiotics. Sixteen patients (43%) died, with a median time from symptom onset to death of 8 days (interquartile range, 7 to 11). Patients who were 40 years of age or older, as compared with those under the age of 40 years, had a relative risk of death of 3.49 (95% confidence interval, 1.42 to 8.59; P=0.007). CONCLUSIONS: Patients with EVD presented with evidence of dehydration associated with vomiting and severe diarrhea. Despite attempts at volume repletion, antimicrobial therapy, and limited laboratory services, the rate of death was 43%.


Assuntos
Desidratação/etiologia , Doença pelo Vírus Ebola/complicações , Doença pelo Vírus Ebola/mortalidade , Adulto , Fatores Etários , Anti-Infecciosos/uso terapêutico , Diarreia/etiologia , Ebolavirus , Epidemias , Feminino , Febre/etiologia , Hidratação , Guiné/epidemiologia , Doença pelo Vírus Ebola/epidemiologia , Humanos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Risco , Taxa de Sobrevida , Taquicardia/etiologia , Vômito/etiologia
2.
Am J Respir Crit Care Med ; 190(7): 733-7, 2014 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-25166884

RESUMO

The largest ever Ebola virus disease outbreak is ravaging West Africa. The constellation of little public health infrastructure, low levels of health literacy, limited acute care and infection prevention and control resources, densely populated areas, and a highly transmissible and lethal viral infection have led to thousands of confirmed, probable, or suspected cases thus far. Ebola virus disease is characterized by a febrile severe illness with profound gastrointestinal manifestations and is complicated by intravascular volume depletion, shock, profound electrolyte abnormalities, and organ dysfunction. Despite no proven Ebola virus-specific medical therapies, the potential effect of supportive care is great for a condition with high baseline mortality and one usually occurring in resource-constrained settings. With more personnel, basic monitoring, and supportive treatment, many of the sickest patients with Ebola virus disease do not need to die. Ebola virus disease represents an illness ready for a paradigm shift in care delivery and outcomes, and the profession of critical care medicine can and should be instrumental in helping this happen.


Assuntos
Cuidados Críticos/métodos , Doença pelo Vírus Ebola/terapia , Assistência ao Paciente/métodos , África Ocidental/epidemiologia , Estado Terminal , Surtos de Doenças/estatística & dados numéricos , Doença pelo Vírus Ebola/epidemiologia , Humanos , Cuidados Paliativos/métodos
3.
Prehosp Disaster Med ; 26(6): 449-56, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22469020

RESUMO

BACKGROUND: The disaster response environment in Haiti following the 2010 earthquake represented a complex healthcare challenge. This study was designed to identify challenges during the Haiti disaster response. METHODS: Qualitative and quantitative study of injured patients carried out six months after the January 2010 earthquake in Haiti to review the surgical inputs of foreign medical teams. RESULTS: Study findings revealed a need during the response for improved medical records and data gathering for regulation, quality assurance, coordination and resource allocation; wider adherence to standard patient referral mechanisms and protocols linking surgical service provision with appropriate hospital and community based rehabilitation services; a greater recognition of the impact of non-amputation injury, and the need for patients to have a greater say in their management and to be the keepers of their medical records. Key first steps to improving the international response are a minimum dataset and uniform reporting. CONCLUSION: This study showed that challenges for emergency medical response during the Haiti Earthquake involved issues of accountability, professional ethics, standards-of-care, unmet needs, patient agency and expected outcomes for patients in such settings:


Assuntos
Terremotos , Procedimentos Cirúrgicos Operatórios/estatística & dados numéricos , Amputação Cirúrgica/estatística & dados numéricos , Amputados/reabilitação , Planejamento em Desastres , Terremotos/estatística & dados numéricos , Serviços Médicos de Emergência , Haiti , Necessidades e Demandas de Serviços de Saúde , Humanos , Avaliação das Necessidades
4.
N Engl J Med ; 355(9): 909-19, 2006 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-16943403

RESUMO

BACKGROUND: An outbreak of Marburg hemorrhagic fever was first observed in a gold-mining village in northeastern Democratic Republic of the Congo in October 1998. METHODS: We investigated the outbreak of Marburg hemorrhagic fever most intensively in May and October 1999. Sporadic cases and short chains of human-to-human transmission continued to occur until September 2000. Suspected cases were identified on the basis of a case definition; cases were confirmed by the detection of virus antigen and nucleic acid in blood, cell culture, antibody responses, and immunohistochemical analysis. RESULTS: A total of 154 cases (48 laboratory-confirmed and 106 suspected) were identified (case fatality rate, 83 percent); 52 percent of cases were in young male miners. Only 27 percent of these men reported having had contact with other affected persons, whereas 67 percent of patients who were not miners reported such contact (P<0.001). Most of the affected miners (94 percent) worked in an underground mine. Cessation of the outbreak coincided with flooding of the mine. Epidemiologic evidence of multiple introductions of infection into the population was substantiated by the detection of at least nine genetically distinct lineages of virus in circulation during the outbreak. CONCLUSIONS: Marburg hemorrhagic fever can have a very high case fatality rate. Since multiple genetic variants of virus were identified, ongoing introduction of virus into the population helped perpetuate this outbreak. The findings imply that reservoir hosts of Marburg virus inhabit caves, mines, or similar habitats.


Assuntos
Surtos de Doenças , Doença do Vírus de Marburg/epidemiologia , Marburgvirus/genética , Adolescente , Adulto , Idoso , Animais , Criança , Pré-Escolar , República Democrática do Congo/epidemiologia , Reservatórios de Doenças , Feminino , Ouro , Humanos , Lactente , Recém-Nascido , Masculino , Doença do Vírus de Marburg/mortalidade , Doença do Vírus de Marburg/transmissão , Doença do Vírus de Marburg/virologia , Marburgvirus/isolamento & purificação , Pessoa de Meia-Idade , Mineração , Estações do Ano , Análise de Sequência de DNA
5.
J Infect Dis ; 196 Suppl 2: S148-53, 2007 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-17940943

RESUMO

The objective of the present study was to describe day of onset and duration of symptoms of Marburg hemorrhagic fever (MHF), to summarize the treatments applied, and to assess the quality of clinical documentation. Surveillance and clinical records of 77 patients with MHF cases were reviewed. Initial symptoms included fever, headache, general pain, nausea, vomiting, and anorexia (median day of onset, day 1-2), followed by hemorrhagic manifestations (day 5-8+), and terminal symptoms included confusion, agitation, coma, anuria, and shock. Treatment in isolation wards was acceptable, but the quality of clinical documentation was unsatisfactory. Improved clinical documentation is necessary for a basic evaluation of supportive treatment.


Assuntos
Doença do Vírus de Marburg/epidemiologia , Animais , República Democrática do Congo/epidemiologia , Progressão da Doença , Documentação , Feminino , Humanos , Masculino , Doença do Vírus de Marburg/mortalidade , Doença do Vírus de Marburg/fisiopatologia , Marburgvirus , Prontuários Médicos , Estudos Retrospectivos , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA